Anti-rabies monoclonal antibody - Serum Institute of India/MassBiologics
Alternative Names: RAB-1; Rabies human monoclonal antibody - Serum Institute of India; Rabishield; RMab; SII RMabLatest Information Update: 04 Oct 2016
At a glance
- Originator Centers for Disease Control and Prevention; MassBiologics; University of Massachusetts Medical School
- Developer Serum Institute of India
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Rabies
Most Recent Events
- 04 Oct 2016 Launched for Rabies in India (IM) before October 2016(Serum Institute of India, October 2016)
- 06 Sep 2013 Isconova is now called Novavax AB
- 22 Aug 2013 Isconova has been acquired by Novavax